Abstract
We report here the results of a retrospective multicenter study of high-dose therapy followed by autologous stem cell transplantation (ASCT) in patients with systemic AL. These results may be considered as the historical experience of autotransplantation for AL in France. This work was published in the British Journal of Haematology 1998;22:645–50.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Moreau, P. et al. (2003). Prognostic factors for survival and response after high-dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients. In: Touchard, G., Aucouturier, P., Hermine, O., Ronco, P. (eds) Monoclonal Gammopathies and the Kidney. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-0191-4_20
Download citation
DOI: https://doi.org/10.1007/978-94-017-0191-4_20
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-6199-7
Online ISBN: 978-94-017-0191-4
eBook Packages: Springer Book Archive